Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Endocrine Therapy Resisted Breast Cancer

NCT03045653 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT03045653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03045653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Endocrine Therapy Resisted Breast Cancer
Lead sponsor
Sun Yat-sen University
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2017
Completion date
February 21, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer metastatic